The Hype Has Faded, but Don’t Count Out Convalescent Plasma in Covid Battle
The once-promising therapy that infuses blood plasma from recovered covid-19 patients into newly infected people, theoretically to boost immunity, has suffered setbacks. But some proponents say it’s too early to abandon the treatment.
http://dlvr.it/Rw6jXW
http://dlvr.it/Rw6jXW
Comments
Post a Comment